LUPIN PHARMACEUTICALS | USA VIEW ALL SPEAKERS To Speak At PV USA CongressClick Here International Companies Attending PV USA VIEW MORE WHO SHOULD ATTEND Pharmacovigilance USA Congress attracts senior level attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution ...
In 2015, five or more biosimilars may be approved in the USA. Because no two biologic medicines are identical, postapproval safety monitoring will be critical to detect potential differences in safety signals between a biosimilar, its reference product, and other biosimilars. Postapproval safety ...
attendees from leading pharmaceutical, biopharmaceutical, biotechnology, diagnostics, CRO and solution provider companies. Delegates includes VPs, Directors, Heads, Managers, Scientific Advisors, Consultants, Senior scientists and professionals with intermediate to advance knowledge and experience in the following...
The platform is engineered with modern technology to facilitate automation-driven process workflows and enables companies to take informed decisions using actionable insights. With highly configurable modules, sponsors and service providers can opt for one or application modules in varying combinations accordi...
companies to adopt PV practices further drive the market. Economic development and growing disposable income make China the fastest-growing market in the region. The National Medical Products Administration (NMPA) issued Good Pharmacovigilance Practices (GVP) in December 2021, mandating compliance for ...
Agility in knowledge translation is important for the responsiveness of a medical system. A similar case emerges with large companies, who become less manoeuvrable as they grow, and many create initiatives meant to speed up their responsiveness and nimbleness [14]. The best organizations combine a...
This, in a nutshell, is the mission of drug safety and highlights the importance of pharmacovigilance, the need for the function within all life science companies and why the discipline plays such a central and important role within pharmaceuticals. Patient safety and continuous vigilance By ...
companies, must have a suitably qualified person responsible for pharmacovigilance. Similarly if the product is being developed or is marketed in the USA there is extensive FDA reporting regulations with strict deadlines that also have to met. A regulation is required to implement the system of ...
companies in the post-marketing pharmacovigilance and medical information market include IQVIA Inc., Parexel International (MA) Corporation, Laboratory Corporation of America Holdings., ICON plc, Syneos Health., Organizations are focusing on increasing customer base to gain a competitive edge in th...
In addition; government regulatory bodies (such as the U.S. FDA and EMEA) have intensified safety regulations for prior and post commercialization of drugs, which has increased pressure on the pharmaceutical and biotechnology companies to manufacture safe drugs and evaluate their results post...